Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to $1.9 million.

  • Immunocore Holdings' Cash from Financing Activities rose 84242.42% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.4 million, marking a year-over-year decrease of 11081.15%. This contributed to the annual value of $343.9 million for FY2024, which is 90122.58% up from last year.
  • Immunocore Holdings' Cash from Financing Activities amounted to $1.9 million in Q3 2025, which was up 84242.42% from $3.7 million recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' Cash from Financing Activities peaked at $396.0 million during Q1 2024, and registered a low of -$51.5 million during Q4 2024.
  • For the 5-year period, Immunocore Holdings' Cash from Financing Activities averaged around $51.1 million, with its median value being $6.2 million (2023).
  • Over the last 5 years, Immunocore Holdings' Cash from Financing Activities had its largest YoY gain of 635075.75% in 2024, and its largest YoY loss of 92364.89% in 2024.
  • Immunocore Holdings' Cash from Financing Activities (Quarter) stood at $9.8 million in 2021, then surged by 204.92% to $29.8 million in 2022, then crashed by 79.01% to $6.3 million in 2023, then crashed by 923.65% to -$51.5 million in 2024, then skyrocketed by 103.62% to $1.9 million in 2025.
  • Its Cash from Financing Activities stands at $1.9 million for Q3 2025, versus $3.7 million for Q2 2025 and $2.6 million for Q1 2025.